Halozyme Therapeutics Inc. buy melinda
Start price
05.01.17
/
50%
€10.73
Target price
10.01.17
€12.63
Performance (%)
19.66%
End price
10.01.17
€12.84
Summary
This prediction ended on 10.01.17 with a price of €12.84. The prediction had a final performance of 19.66%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Halozyme Therapeutics Inc. | 3.082% | 3.082% | 20.018% | 2.293% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by melinda for this prediction
In the thread Halozyme Therapeu. diskutieren
folgen
$ HALO Viel Glück mit dem Ph 3 , wenn dies der "Stärkste" du hast Beweise von einem Ph2 Open-Label - Studie ..
Stopped prediction by melinda for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.80
29.09.19
29.09.19
€30.00
04.11.21
04.11.21
155.29%
05.11.21
05.11.21
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.46
15.09.17
15.09.17
€20.75
18.09.17
18.09.17
4.83%
18.09.17
18.09.17
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.27
07.04.17
07.04.17
€12.63
21.04.17
21.04.17
6.57%
21.04.17
21.04.17
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.07
25.02.17
25.02.17
€12.63
06.03.17
06.03.17
7.25%
06.03.17
06.03.17